Informed consent: time for more transparency

Area of Science:

• Clinical research ethics
• Patient advocacy
• Public health communication

Background:

• Informed consent is traditionally viewed as documentation for patient enrollment in clinical trials.
• Current clinical trial registries lack integrated informed consent documents.
• There is a need for enhanced transparency in clinical trial information dissemination.

Purpose of the Study:

• To propose expanding the role of informed consent beyond trial enrollment.
• To advocate for informed consent to serve as a primary information source for patients and the public.
• To recommend the inclusion of informed consent within clinical trial registries.

Main Methods:

• Literature review on current informed consent practices.
• Analysis of clinical trial registry structures and content.
• Proposal development based on ethical principles and public health communication strategies.

Main Results:

• Informed consent documents currently do not include details on study rationale, existing knowledge, or expected outcomes (efficacy/harm).
• Clinical trial registries do not incorporate informed consent forms.
• A gap exists in providing comprehensive study information to patients and the public.

Conclusions:

• Informed consent should be redefined as a crucial source of information for patients and the public regarding clinical trials.
• Integrating informed consent into clinical trial registries is essential for complete disclosure.
• This integration will enhance patient understanding and public trust in clinical research.